Analyst Dara Mohsenian from Morgan Stanley maintained a Buy rating on Keurig Dr Pepper and keeping the price target at $40.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Dara Mohsenian has given his Buy rating due to a combination of factors including Keurig Dr Pepper’s solid organic sales growth (OSG) and maintained full-year earnings per share (EPS) guidance. The company’s recent performance, particularly in the coffee segment, shows signs of recovery, with sales stabilizing after a period of decline. This improvement, alongside favorable pricing dynamics, suggests a positive outlook for future growth.
Furthermore, the valuation of Keurig Dr Pepper appears attractive, trading at a discount compared to its peers despite its strong sales performance. Mohsenian believes that the company’s ability to manage costs and maintain pricing power, even in the face of rising coffee costs and tariffs, positions it well for continued success. The potential for 19% upside in the stock price further supports the Buy recommendation.
In another report released yesterday, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $37.00 price target.
Based on the recent corporate insider activity of 46 insiders, corporate insider sentiment is neutral on the stock.